Akin Kabalak, Pinar; Kizilgoz, Derya; Yilmaz, Ulku; Demirag, Funda
(2021)
Aim: The initial mutation status of non-small cell lung cancer (NSCLC) is important for guiding treatment. However, re-biopsy is needed to determine the new mutation status in patients receiving targeted therapy or who ...